Zum Inhalt springen Zur Suche springen

Publikationen

* shared corresponding author, + shared first author

22. Wagner B., Smiesko M., Jakob R. P., Mühletaler T., Cramer J., Maier T., Rabbani S., Schwardt O., Ernst B. Analogues of the pan-selectin antagonist rivipansel (GMI-1070), Eur. J. Med. Chem., 2024, 116455, https://doi.org/10.1016/j.ejmech.2024.116455.

21. Nemli D. D., Jiang X., Jakob R. P., Muñoz Gloder L., Schwardt O., Rabbani S., Maier T., Ernst B.,* Cramer J.* Thermodynamics-Guided Design Reveals a Cooperative Hydrogen Bond in DC-SIGN-targeted Glycomimetics, J. Med. Chem., 2024, doi.org/10.1021/acs.jmedchem.4c00623. Selected for the Front Cover.

20. Cramer J., Pero B., Jiang X., Bosko C, Silbermann M., Rabbani S., Wilke S., Nemli D. D., Ernst B., Peczuh M. Does size matter? – Comparing pyranoses with septanoses as ligands of the bacterial lectin FimH , Eur. J. Med. Chem., 2024, 116225, https://doi.org/10.1016/j.ejmech.2024.116225.

19. Cramer J.,* Jiang X., Aliu B., Ernst B.* Combating DC-SIGN-mediated SARS-CoV-2 Dissemination by Glycan-mimicking Polymers , Arch. Pharm., 2023, e2300396, doi.org/10.1002/ardp.202300396.

18. Frank M., Kuhfeldt E., Cramer J., Watzl C., Prescher H. Synthesis and Binding Mode Predictions of Novel Siglec-7 Ligands. J. Med. Chem. 2023, 66 (20), 14314–14334.

17. Cramer J., Pang L., Ernst B. Antiadhesive Carbohydrates and Glycomimetics. In Carbohydrate‐Based Therapeutics (eds R. Adamo and L. Lay), 10.1002/9783527831326.ch52023, 2023, pp 131-160.

16. Gorzkiewicz M., Cramer J., Xu H.C., Lang P. A. The role of glycosylation patterns of viral glycoproteins and cell entry receptors in arenavirus infection, Biomed. Pharmacother. 2023, 166, 115196.

15. Bozzola T., Scalise M., Larsson C.U., Newton-Vesty M.C., Rovegno C., Mitra A., Cramer J., Wahlgren Y.W., Santhakumari P.R., Johnsson R.E., Schwardt O., Ernst B., Friemann R., Dobson R.C.J., Indiveri C., Schelin J., Nilsson U.J., Ellervik U. Sialic Acid Derivatives Inhibit SiaT Transporters and Delay Bacterial Growth, ACS Chem. Biol. 2022, 17, 7, 1890–1900.

14. Cramer J., Lakkaichi A., Aliu B., Jakob R.P., Klein S., Cattaneo I., Jiang, X., Rabbani S., Schwardt O., Zimmer G., Ciancaglini M., Abreu-Mota T., Maier T., Ernst B. Sweet Drugs for Bad Bugs: A Glycomimetic Strategy Against the DC-SIGN-mediated Dissemination of SARS-CoV-2, J. Am. Chem. Soc., 2021, 143 (42), 17465–17478.

13. Cramer J., Medicinal Chemistry of the Myeloid C-Type Lectin Receptors Mincle, Langerin, and DC-SIGN, RSC Medicinal Chemistry, 2021, 12, 1985–2000. Selected for Emerging Investigators collection.

12. Cramer J.,*+ Aliu B.,+ Jiang X., Sharpe T., Pang L., Hadorn A., Rabbani S., Ernst B.*, Poly-l-lysine Glycoconjugates Inhibit DC-SIGN-mediated Attachment of Pandemic Viruses, ChemMedChem. 2021, 16 (15), 2345–2353. Part of the „EuroMedChem Talents” article collection

11. Lal K., Bermeo R., Cramer J., Vasile F., Ernst B., Imberty A., Bernardi A., Varrot A., Belvisi L., Prediction and Validation of a Druggable Site on Virulence Factor of Drug Resistant Burkholderia cenocepacia, Chem. Eur. J. 2021, 27 (40), 10341–10348.

10. Cramer J., Jiang X., Schönemann W., Silbermann M., Zihlmann P., Siegrist S., Fiege B., Jakob R. P., Rabbani S., Maier T., Ernst B., Enhancing the Enthalpic Contribution of Hydrogen Bonds by Solvent Shielding, RSC Chem. Biol. 2020, 1, 281. Highlighted in „Editor’s choice” article collection

9. Kroezen B., Conti G., Girardi B., Cramer J., Jiang X., Rabbani S., Müller J., Kokot M., Luisoni E., Ricklin D., Schwardt O., Ernst B. A Potent Mimetic of the Siglec‐8 Ligand 6’‐Sulfo‐Sialyl Lewisx, ChemMedChem 2020, 18, 1706-1719. Front Cover and highlight as “Very Important Paper”.

8. Cramer J.,* Sager C. P., Ernst B.* Hydroxyl Groups in Synthetic and Natural-Product-Derived Therapeutics: A Perspective on a Common Functional Group, J. Med. Chem., 2019, 62, 8915–8930.

7. Schönemann W., Cramer J., Mühlethaler T., Fiege B., Silbermann M., Rabbani S., Dätwyler P., Zihlmann P., Jakob R. P., Sager C. P., Smiesko M., Schwardt O., Maier T., Ernst B. Improvement of Aglycone π-Stacking Yields Nanomolar to Sub-nanomolar FimH Antagonists, ChemMedChem, 2019, 14, 749–757. Front Cover and highlight as “Very Important Paper”.

6. Krimmer S. G.,+ Cramer J.,+ Schiebel J., Heine A., Klebe G. How Nothing Boosts Affinity: Hydrophobic Ligand Binding to the Virtually Vacated S1' Pocket of Thermolysin, J. Am. Chem. Soc., 2017, 139, 10419–10431. Highlighted in science blog “In the Pipeline

5. Cramer J., Krimmer S. G., Heine A., Klebe G. Paying the Price of Desolvation in Solvent-Exposed Protein Pockets: Impact of Distal Solubilizing Groups on Affinity and Binding Thermodynamics in a Series of Thermolysin Inhibitors, J. Med. Chem., 2017, 60, 5791–5799. Highlighted by F1000 prime

4. Cramer J., Schiebel J., Wulsdorf T., Grohe K., Najbauer E., Ehrmann F. R., Radeva N., Zitzer N., Linne U., Linser R., Heine A., Klebe G. A False-Positive Screening Hit in Fragment-Based Lead Discovery: Watch out for the Red Herring, Angew. Chem. Int. Ed., 2017, 7, 1908–1913. Highlighted in science blog “Practical Fragments

3. Cramer J., Klebe G. An Allyl Protection and Improved Purification Strategy Enables the Synthesis of Functionalized Phosphonamidate Peptides, Synthesis, 2017, 49, 1857–1866.

2. Cramer J., Krimmer S. G., Fridh V., Wulsdorf T., Karlsson R., Heine A., Klebe G. Elucidating the Origin of Long Residence Time Binding for Inhibitors of the Metalloprotease Thermolysin, ACS Chem. Biol., 2017, 12, 225–233.

1. Krimmer S. G.,+ Cramer J.,+ Betz M., Fridh V., Karlsson R., Heine A., Klebe G. Rational Design of Thermodynamic and Kinetic Binding Profiles by Optimizing Surface Water Networks Coating Protein Bound Ligands, J. Med. Chem., 2016, 59, 10530–10548. Highlighted by F1000 prime